Advertisement

Topics

GLAUKOS CORPORATION Company Profile

18:36 EST 18th November 2017 | BioPortfolio

Glaukos Corporation is committed to transforming glaucoma therapy. To this end, Glaukos is bypassing anatomical impediments and treatment conventions to develop treatments that restore natural physiologic outflow as a foundation of significant, steady and sustained glaucoma management.
Today, we are at the beginning with an innovative micro technology. In collaboration with our clinician partners, we are building technology towards a safer and more effective treatment for preserving vision in patients with primary open-angle glaucoma.

Location

26051 Merit Circle Suite 103
Laguna Hills
California
92653
United States of America

Contact

Phone: 949.367.9600
Fax: 949.367.9984
Email: contact@glaukos.com


News Articles [80 Associated News Articles listed on BioPortfolio]

Glaukos Announces Participation in Wells Fargo Healthcare Conference

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to tra...

Glaukos Announces Participation in Stifel 2017 Healthcare Conference

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to tra...

Glaukos Announces 2017 Investor Day and Webcast

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to tra...

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation

IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

Glaukos Corporation to Release Third Quarter 2017 Financial Results after Market Close on November 7

Conference Call and Webcast Scheduled for 1:30 p.m. PST Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercializa...

Glaukos reports $3.3 million net loss in second quarter

Glaukos reported a net loss of $3.3 million, or $0.10 per diluted share, in the second quarter of 2017 compared with a net income of $2.3 million, or $0.06 per diluted share, in the second quarter of ...

Glaukos Corporation to Release Second Quarter 2017 Financial Results after Market Close on August 2

Conference Call and Webcast Scheduled for 1:30 p.m. PDT Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercializa...

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects

The purpose of this study is to evaluate the safety and efficacy of the iStent trabecular micro-bypass stent in reducing intraocular pressure (IOP) in refractory open-angle glaucoma subjec...

A Comparison of Cataract Surgery Alone and Cataract Surgery With iStent

Glaucoma is the commonest cause of irreversible blindness in the world. Treatment centres around lowering intraocular pressure (IOP) and typically includes medication (least invasive), las...

Companies [171 Associated Companies listed on BioPortfolio]

GLAUKOS CORPORATION

Glaukos Corporation is committed to transforming glaucoma therapy. To this end, Glaukos is bypassing anatomical impediments and treatment conventions to develop treatments that restore natural physiol...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

Hot Spring Spas

Hot Spring Spas is the world’s leading brand of hot tubs and is sold through a network of more than 700 independent dealers throughout North America and 70 countries around t...

More Information about "GLAUKOS CORPORATION" on BioPortfolio

We have published hundreds of GLAUKOS CORPORATION news stories on BioPortfolio along with dozens of GLAUKOS CORPORATION Clinical Trials and PubMed Articles about GLAUKOS CORPORATION for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GLAUKOS CORPORATION Companies in our database. You can also find out about relevant GLAUKOS CORPORATION Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record